BG99495A - Pharmaceutical compounds - Google Patents

Pharmaceutical compounds

Info

Publication number
BG99495A
BG99495A BG99495A BG9949595A BG99495A BG 99495 A BG99495 A BG 99495A BG 99495 A BG99495 A BG 99495A BG 9949595 A BG9949595 A BG 9949595A BG 99495 A BG99495 A BG 99495A
Authority
BG
Bulgaria
Prior art keywords
pct
nco2r11
nhco
alkyl
sec
Prior art date
Application number
BG99495A
Other languages
Bulgarian (bg)
English (en)
Inventor
Mark Collins
Maria Chicarelli-Robinson
John Shaw
Justin Bryans
Christopher Latham
Stephen Brocchini
Original Assignee
Xenova Limited
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Xenova Limited filed Critical Xenova Limited
Publication of BG99495A publication Critical patent/BG99495A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
    • C07D241/02—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
    • C07D241/06—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having one or two double bonds between ring members or between ring members and non-ring members
    • C07D241/08—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having one or two double bonds between ring members or between ring members and non-ring members with oxygen atoms directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
    • C07D241/02—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
BG99495A 1992-08-14 1995-03-13 Pharmaceutical compounds BG99495A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB929217331A GB9217331D0 (en) 1992-08-14 1992-08-14 Pharmaceutical compounds
PCT/GB1993/001734 WO1994004512A1 (en) 1992-08-14 1993-08-16 Pharmaceutically active diketopiperazines

Publications (1)

Publication Number Publication Date
BG99495A true BG99495A (en) 1995-12-29

Family

ID=10720385

Family Applications (2)

Application Number Title Priority Date Filing Date
BG99495A BG99495A (en) 1992-08-14 1995-03-13 Pharmaceutical compounds
BG99496A BG99496A (en) 1992-08-14 1995-03-13 Pharmaceutical compounds

Family Applications After (1)

Application Number Title Priority Date Filing Date
BG99496A BG99496A (en) 1992-08-14 1995-03-13 Pharmaceutical compounds

Country Status (24)

Country Link
US (1) US5700804A (fi)
EP (2) EP0655060B1 (fi)
JP (2) JPH08504176A (fi)
KR (2) KR950702968A (fi)
AT (1) ATE162186T1 (fi)
AU (2) AU693420B2 (fi)
BG (2) BG99495A (fi)
BR (2) BR9306905A (fi)
CA (2) CA2141938A1 (fi)
CZ (2) CZ38195A3 (fi)
DE (1) DE69316370T2 (fi)
DK (1) DK0655060T3 (fi)
ES (1) ES2111169T3 (fi)
FI (2) FI950617A (fi)
GB (2) GB9217331D0 (fi)
GR (1) GR3026272T3 (fi)
HU (2) HUT71592A (fi)
IL (2) IL106696A0 (fi)
PL (2) PL307437A1 (fi)
RU (2) RU95108759A (fi)
SK (2) SK19595A3 (fi)
TW (1) TW334427B (fi)
WO (2) WO1994004513A1 (fi)
ZA (2) ZA935969B (fi)

Families Citing this family (54)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9217331D0 (en) * 1992-08-14 1992-09-30 Xenova Ltd Pharmaceutical compounds
DK85193D0 (da) 1993-07-16 1993-07-16 Cancerforskningsfondet Af 1989 Suppression of inhibitors
GB9402805D0 (en) * 1994-02-14 1994-04-06 Xenova Ltd Pharmaceutical compounds
IL112627A0 (en) * 1994-02-14 1995-05-26 Xenova Ltd Diketopiperazines, their preparation and pharmaceutical or veterinary compositions containing them
GB9402809D0 (en) * 1994-02-14 1994-04-06 Xenova Ltd Pharmaceutical compounds
GB9402807D0 (en) * 1994-02-14 1994-04-06 Xenova Ltd Pharmaceutical compounds
GB9410387D0 (en) * 1994-05-24 1994-07-13 Xenova Ltd Pharmaceutical compounds
GB9426224D0 (en) * 1994-12-23 1995-02-22 Xenova Ltd Pharmaceutical compounds
GB9426090D0 (en) * 1994-12-23 1995-02-22 Xenova Ltd Pharmaceutical compounds
GB2311781B (en) * 1994-12-23 1998-09-16 Xenova Ltd Piperazine 2,5 dione derivatives as modulators of multi-drug resistance
GB2310854B (en) * 1994-12-23 1998-09-09 Xenova Ltd Piperazine-2,5-dione derivatives as modulators of multi-drug resistance
GB9426071D0 (en) * 1994-12-23 1995-02-22 Xenova Ltd Pharmaceutical compounds
US5891877A (en) * 1995-02-14 1999-04-06 Xenova Limited Pharmaceutical compounds
JP2003515590A (ja) * 1999-12-03 2003-05-07 エモリー ユニバーシティ 癌を処置するためのクルクミンアナログ
US6635649B2 (en) 2000-05-09 2003-10-21 Che-Ming Teng Piperazinedione compounds
US7288545B2 (en) * 2000-05-09 2007-10-30 Angiorx Corporation Piperazinedione compounds
CA2774959C (en) 2000-08-04 2016-05-31 Dmi Biosciences, Inc. Method of using diketopiperazines and composition containing them
ATE377048T1 (de) 2000-09-06 2007-11-15 Ap Pharma Inc Abbaubare polyacetal-polymere
US6693099B2 (en) 2000-10-17 2004-02-17 The Procter & Gamble Company Substituted piperazine compounds optionally containing a quinolyl moiety for treating multidrug resistance
WO2002062797A2 (en) * 2000-12-29 2002-08-15 Celltech R & D, Inc. Pharmaceutical uses and synthesis of diketopiperazines
GB2372740A (en) * 2001-01-17 2002-09-04 Xenova Ltd Diketopiperazines
US20060229239A9 (en) * 2002-03-08 2006-10-12 Mamoru Shoji Novel curcuminoid-factor VIIa constructs as suppressors of tumor growth and angiogenesis
US7935704B2 (en) 2003-08-01 2011-05-03 Nereus Pharmaceuticals, Inc. Dehydrophenylahistins and analogs thereof and the synthesis of dehydrophenylahistins and analogs thereof
PT1529044E (pt) 2002-08-02 2008-01-14 Nereus Pharmaceuticals Inc Desidrofenila-histinas e os seus análogos e a síntese de desidrofenila-histinas e os seus análogos
US7919497B2 (en) 2002-08-02 2011-04-05 Nereus Pharmaceuticals, Inc. Analogs of dehydrophenylahistins and their therapeutic use
DE10238144A1 (de) * 2002-08-15 2004-02-26 Basf Ag Verwendung von Diketopiperazin-Derivaten als photostabile UV-Filter in kosmetischen und pharmazeutischen Zubereitungen
EP1571970B1 (en) 2002-10-02 2011-08-17 DMI Biosciences, Inc. Diagnosis and monitoring of diseases
CN103191409A (zh) * 2003-05-15 2013-07-10 Dmi生物科学公司 T-细胞介导的疾病的治疗
GB0314738D0 (en) 2003-06-24 2003-07-30 Glaxo Group Ltd Novel compounds
US7732605B2 (en) 2005-03-29 2010-06-08 Nereus Pharmaceuticals, Inc. Synthesis of diketopiperazines
US20070270464A1 (en) * 2006-02-24 2007-11-22 Emory University Prodrugs of curcumin analogs
US8129527B2 (en) 2006-11-03 2012-03-06 Nereus Pharmacuticals, Inc. Analogs of dehydrophenylahistins and their therapeutic use
US8217047B2 (en) 2008-05-27 2012-07-10 Dmi Acquisition Corp. Therapeutic methods and compounds
CA2810844C (en) 2010-09-07 2017-03-21 Dmi Acquisition Corp. Diketopiperazine compositions for the treatment of metabolic syndrome and related conditions
KR20140027937A (ko) * 2011-02-10 2014-03-07 맨카인드 코포레이션 Ｎ­보호된 비스­３，６­（４­아미노알킬）­２，５，디케토피페라진의 생성
EA027343B1 (ru) 2011-10-10 2017-07-31 Ампио Фармасьютикалз, Инк. Имплантируемые устройства медицинского назначения с повышенной иммунной толерантностью и способы изготовления и имплантирования
CN104958752B (zh) 2011-10-10 2019-01-18 安皮奥制药股份有限公司 退行性关节病的治疗
JP6231484B2 (ja) 2011-10-28 2017-11-15 アンピオ ファーマシューティカルズ，インコーポレイテッド 鼻炎の処置
KR20150132508A (ko) 2013-03-15 2015-11-25 앰피오 파마슈티컬스 인코퍼레이티드 줄기세포의 가동화, 회귀, 증식 및 분화를 위한 조성물 및 이의 사용 방법
CN103396372B (zh) * 2013-08-09 2015-05-20 中国科学院南海海洋研究所 一类2,5-二酮哌嗪衍生物及其制备方法和在制备抗海洋污损生物防除剂中的应用
CN105272968B (zh) * 2014-06-10 2018-03-13 首都医科大学 (3s,6r)‑3,6二取代哌嗪‑2,5‑二酮,其制备及应用
KR20170045274A (ko) 2014-08-18 2017-04-26 앰피오 파마슈티컬스 인코퍼레이티드 관절 징후의 치료
CN104610170B (zh) * 2015-01-14 2017-02-01 中国科学院南海海洋研究所 2,5‑二酮哌嗪衍生物及其制备方法和应用
RU2728796C2 (ru) 2015-03-06 2020-07-31 Бейондспринг Фармасьютикалс, Инк. Способ лечения опухоли головного мозга
MY190034A (en) 2015-03-06 2022-03-22 Beyondspring Pharmaceuticals Inc Method of treating cancer associated with a ras mutation
EP3310375A4 (en) 2015-06-22 2019-02-20 Ampio Pharmaceuticals, Inc. USE OF LOW MOLECULAR WEIGHT HUMAN SERUM ALBUMIN FRACTIONS FOR TREATING DISEASES
PE20180528A1 (es) 2015-07-13 2018-03-19 Beyondspring Pharmaceuticals Inc Composiciones de plinabulina
MX2018009413A (es) 2016-02-08 2019-05-15 Beyondspring Pharmaceuticals Inc Composiciones que contienen tucaresol o sus analogos.
TWI777957B (zh) 2016-06-06 2022-09-21 中國大陸商大連萬春布林醫藥有限公司 降低嗜中性白血球減少症之組合物及方法
EP3565812B1 (en) 2017-01-06 2023-12-27 Beyondspring Pharmaceuticals, Inc. Tubulin binding compounds and therapeutic use thereof
BR112019015974A2 (pt) 2017-02-01 2020-03-31 Beyondspring Pharmaceuticals, Inc. Método para reduzir neutropenia
CN110054619A (zh) * 2018-01-18 2019-07-26 西北农林科技大学 新型二酮哌嗪类组蛋白去乙酰化酶抑制剂
KR20200112881A (ko) 2018-01-24 2020-10-05 비욘드스프링 파마수티컬스, 인코포레이티드. 플리나불린의 투여를 통해 혈소판감소증을 감소시키는 조성물 및 방법
US11129878B1 (en) 2020-03-24 2021-09-28 Ampio Pharmaceuticals, Inc. Methods for treating diseases associated with respiratory viruses

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE621862C (de) * 1932-07-01 1935-11-14 Guenther Schiemann Dr Verfahren zur Darstellung von Kondensationsprodukten kernfluorierter Arylaldehyde
BE584914A (fi) * 1958-11-24
JPS5747357A (en) * 1980-09-04 1982-03-18 Ricoh Co Ltd Novel disazo compound and its preparation
GB9217331D0 (en) * 1992-08-14 1992-09-30 Xenova Ltd Pharmaceutical compounds

Also Published As

Publication number Publication date
RU95108759A (ru) 1996-12-10
AU678172B2 (en) 1997-05-22
KR950702968A (ko) 1995-08-23
US5700804A (en) 1997-12-23
ES2111169T3 (es) 1998-03-01
ATE162186T1 (de) 1998-01-15
IL106696A0 (en) 1993-12-08
GB2284420A (en) 1995-06-07
HU9500437D0 (en) 1995-04-28
DK0655060T3 (da) 1998-02-09
DE69316370D1 (de) 1998-02-19
GB2284420B (en) 1996-09-25
WO1994004513A1 (en) 1994-03-03
ZA935969B (en) 1995-02-16
WO1994004512A1 (en) 1994-03-03
PL307438A1 (en) 1995-05-29
BR9306905A (pt) 1998-12-08
BG99496A (en) 1995-12-29
EP0655060A1 (en) 1995-05-31
SK19595A3 (en) 1995-09-13
DE69316370T2 (de) 1998-07-16
CA2141939A1 (en) 1994-03-03
CA2141938A1 (en) 1994-03-03
FI950617A0 (fi) 1995-02-13
CZ38195A3 (en) 1995-09-13
HUT71593A (en) 1996-01-29
KR950702967A (ko) 1995-08-23
EP0655060B1 (en) 1998-01-14
RU95108387A (ru) 1996-12-10
EP0672036A1 (en) 1995-09-20
FI950616A (fi) 1995-04-13
HU9500436D0 (en) 1995-04-28
AU4726593A (en) 1994-03-15
GB9217331D0 (en) 1992-09-30
IL106695A0 (en) 1993-12-08
FI950617A (fi) 1995-04-13
GR3026272T3 (en) 1998-06-30
FI950616A0 (fi) 1995-02-13
JPH08504175A (ja) 1996-05-07
SK19495A3 (en) 1995-11-08
JPH08504176A (ja) 1996-05-07
PL307437A1 (en) 1995-05-29
AU4726493A (en) 1994-03-15
TW334427B (en) 1998-06-21
HUT71592A (en) 1996-01-29
AU693420B2 (en) 1998-07-02
BR9306904A (pt) 1998-12-08
GB9502859D0 (en) 1995-04-05
CZ38395A3 (en) 1995-10-18
ZA935968B (en) 1995-02-16

Similar Documents

Publication Publication Date Title
ZA935969B (en) Pharmaceutical compounds
TW274547B (fi)
NZ511739A (en) New esters derived from substituted phenyl-cyclohexyl compounds
GR3036688T3 (en) 5-azabicyclo(3.1.0)hexylalkyl-2-piperidones and -glutarimides as neurokinin receptor antagonists
IT1275433B (it) Derivati di diarildiammine
IL105715A (en) 7b SUBSTITUTED-4-AZA-5a- ANDROSTAN-3-ONES AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
ATE193313T1 (de) Poly(oxyalkylen)hydroxyaromatische ester und diese enthaltende brennstoffzusammensetzungen
MY131387A (en) Novel 4-benzoylisoxazole derivatives, compositions containing them, processes for their preparation, intermediates in their and their use as herbicides
ES2093523T3 (es) Catalizadores quirales y reacciones de epoxidacion catalizadas por los mismos.
TW283704B (fi)
IL107389A (en) N-substituted carbonyloxyalkyl- pyrroles and insecticidal, acaricidal and molluscicidal compositions containing them
GB2284602A (en) Pharmaceutically active diketopiperazines
MX9707201A (es) Derivados de 1-carba-(detia)-cefalosporina.